small proline rich proteins; airway epithelium; transcriptional regulation; mitogen-activated protein kinases; Jun/ Fos; c-Jun NH 2-terminal kinase 1; activator protein 1 PHORBOL 13-MYRISTATE 12-ACETATE (PMA), a stable functional analog of diacylglycerol, is produced in vivo by hydrolysis of phospholipids, which induces diverse biological responses. PMA mainly activates several protein kinase C (PKC) isoenzymes, which in turn initiate a signaling cascade to regulate the expression of genes that are involved in cell growth and differentiation in response to environmental stimuli including cellular injury repair, inflammation, and acute phase response. Clara cells are the progenitor cell type for the distal bronchiolar epithelium during injury and repair (16) . Administration of PMA, which induces acute and progressive lung injury (12) , downregulates the expression of human surfactant protein gene expression in both human fetal lung implants and in Clara-like bronchiolar epithelial cell line H441 (9, 13, 15, 19, 20) . PMA also potently induces squamous cell differentiation (SCD) in tracheobronchial epithelial (TBE) cells in vivo and in vitro. Previous studies have shown a close relationship between an early induction of human small proline-rich protein type I (SPRR1) and SCD in TBE cells (27, review) . Tobacco smoke, which potently induces SCD in airway epithelium, enhances the expression of SPRR1 in nasal (28) and bronchial epithelium (22) . Subsequently, it was shown that PMA (1, 21) and tobacco smoke (22) induce expression of SPRR1 (now referred to as SPRR1B) in TBE cells, which occurs primarily at the transcriptional level and is mediated by the TRE sites and activator proteins (AP)-1.
The distal bronchiolar region represents a major target for pulmonary toxicity induced by various environmental toxicants and pollutants (16) . Several studies have demonstrated that the exposure of animals to toxicants, such as naphthalene, selectively induces cellular injury in distal bronchiolar region (25, 29) . For example, naphthalene at lower levels (50-100 mg/kg body wt) induces Clara cellular injury in the distal airway region, whereas proximal airways require a substantially higher dose (Ͼ300 mg/kg) (17) . Later studies attributed this difference to a higher level of cytochrome P-450 isoenzyme 2F2, which converts naphthalene to an active metabolite, 1R, 2S-naphthalene, in distal airway region compared with proximal airways (3) . Conversely, the content of glutathione, which plays a protective role in cellular detoxification, is higher in upper airways compared with distal bronchiolar region (18) . Together these studies indicate certain differences in the mechanisms governing cellular injury and repair process in upper and distal airway regions. Naphthalene suppresses the expression of Clara cell differentiation (CCD) markers and greatly enhances the expression of squamous cell functions (29) . Moreover, exposure of mice to naphthalene and tobacco smoke greatly enhances the expression SPRR1B in distal bronchiolar region (Reen Wu, University of California at Davis, Davis, CA; personal communication). However, the exact molecular mechanisms governing the regulation of cell proliferation and differentiation in response to injury, in particular the induction of SCD, in the distal bronchiolar region, are not clearly understood. Based on certain differences involved in injury and repair mechanisms, we hypothesized that the induction of SCD in the distal bronchiolar region is regulated by a mechanism different from those that operate in the proximal airway epithelium. In the present study, we used Clara-like bronchiolar epithelial cell culture (H441) as a model system to study the regulation of CCE precursor protein gene expression and to understand the molecular mechanisms involved in the induction of SCD in the distal bronchiolar region. Here, we present for the first time evidence for a PMA-inducible expression of SPRRs in distal bronchiolar cells H441. Promoter analysis indicates that, similar to proximal TBE cells (S-6), PMA-stimulated SPRR1B expression in H441 cells requires the same TREs (PMA-responsive elements or AP-1 sites) and combination of AP-1 proteins. However, unlike in S6 cells, c-Jun NH 2 -terminal kinase (JNK) 1, a mitogen-activated protein kinase (MAPK), is critical for PMA-inducible SPRR1B expression in H441 cells. Thus the activation of different signaling pathways might contribute to the induction of SCD in the distal bronchiolar region.
MATERIALS AND METHODS

Cell culture, Northern blot, RT-PCR, and Western blot
analyses. NCI-H441 (Clara-like bronchiolar pulmonary adenocarcinoma) cell line was obtained from ATCC. All cells were maintained in RPMI culture medium supplemented with 5% serum, 1% streptomycin and penicillin, gentamicin (250 ng/ml), and fungizone (125 ng/ml). Cells were treated with either vehicle (DMSO) or PMA (25 ng/ml) for the indicated time periods. Total RNA (20 g/lane) was separated on a 1.2% agarose gel and transblotted. Northern blot analysis was carried out using 32 P-labeled cDNAs of SPRR1B as previously described (31) . RT-PCR was performed as previously described (14) . Briefly, total RNA (750 ng) was reverse transcribed into cDNA, and PCR amplification was performed with an aliquot of cDNA using gene-specific primer pairs (see Table 1 ). The indicated number of cycles were employed to amplify the product in a linear range. The amplified cDNA fragments were separated and quantified with the Gel Doc 2000 System (Bio-Rad). Western blot analysis of cellular extracts isolated from untreated and PMAtreated H441 cells was performed using polyclonal antibodies of human SPRR1B (10) .
Transient transfections and reporter gene assays. The wildtype (wt), dominant negative (dn), and constitutively active (ca) expression vectors were kindly provided by the following: the dn-mitogen-activating protein kinase kinase (MAPKK) 1 and ca-MAPKK1 cloned in pCMV vector, Dennis Templeton, Case Western Reserve University, Cleveland, OH; dn-JNK1 cloned in pCDNA3 vector, Roger Davis, Howard Hughes Medical Institute, Rochester, NY; dn-extracellular signalregulated kinase (ERK) 1 and dn-ERK2 cloned in pCEP4 vector, Melanie Cobb, University of Texas Southwestern Medical Center, Dallas, TX; wt-c-Jun and dn-c-Jun (has mutations in transactivation domain) cloned in pCMV vector, Michael Birrer, National Cancer Institute, Bethesda, MD; wt-JunB and wt-JunD cloned in SR-alpha vector, Michael Karin, University of California at San Diego, San Diego, CA; wt-Fra1 cloned in pCMV vector, Eugene Tulchinsky, Institute of Cancer Biology, Copenhagen, Denmark; and wt-Fra2 cloned pCMV vector, Donna Cohen, Australian National University, Canberra, Australia; dn-Raf (Raf-C4) cloned in pRSV vector (Stephen Ludwig, Institut fü r Medizinische Strahlenkunde und Zellforschung, Wü rzburg, Germany) were obtained. Dn-Ras (Ras-N17) and ca-Ras (Ha-Ras-V12) were generated as previously described (31) . Several deletion and site-directed mutational fragments of the Ϫ150 to ϩ12-bp SPRR1B promoter fused to the luciferase (Luc) gene as described previously (21) . DNA transfections were performed using a Fugene transfection reagent (Roche Biochemical). Cells were grown on 48-well plates at 70-80% confluence Gene-specific primer sets are shown with the expected amplified fragment sizes (bp), annealing temperatures, and the number of PCR cycles. SPRR, small proline-rich protein.
and then transfected with 100 ng of promoter construct, 50 ng of CMV-␤-galactosidase (␤-gal) DNA, and 50-200 ng of empty or expression plasmid vectors. After 18-20 h posttransfection, cells were treated with either DMSO or PMA (25 ng/ml) for 14-16 h. Cells were lysed, and Luc activity was measured using a commercially available kit (Promega). Luc activity of individual samples was normalized against ␤-gal activity and/or total protein as described previously (31) . Luc activity for every construct was analyzed in duplicate samples, and all experiments were repeated three to four times.
Electrophoretic mobility shift assay. Nuclear extracts from DMSO-or PMA-treated H441 cells were prepared, and electrophoretic mobility shift assay (EMSA) was performed as described previously (14) with 0.1-0.5 ng of 32 P-end-labeled consensus AP-1 site or Ϫ150-to Ϫ84-bp SPRR1B promoter fragment (for sequence see Table 2 ). For supershift analysis, nuclear extracts were mixed with 1-2 g of c-Jun (sc-45X), JunB (sc-46X), JunD (sc-74X), c-Fos (sc-7202X), Fra1 (sc605x), and Fra2 (sc-604X) antibodies (Santa Cruz Biotechnology) and incubated on ice for 1-2 h before the labeled DNA probe was added.
In vitro kinase assays and immunoblot analysis. H441 cells were cultured to 70-80% confluence and treated with PMA (25 ng/ml) for indicated time periods, and assays were performed as previously described (31) . Briefly, 200 g of cellular protein were immunoprecipitated using 0.4 g antibodies derived against JNK1 (C-17) or p38 (C-20) kinases (Santa Cruz Biotechnologies) that were conjugated to protein ASepharose (Pharmacia). The immunoprecipitates were washed extensively, and the kinase activities of JNK1 and p38 were determined as previously described (31) . Active ERK1/2, p38, and JNK1 immunoblot analysis was carried out using the phospho-specific antibodies as previously described (31) . Total ERK, p38, and JNK1 content of the samples was determined by immunoblot analysis using ERK, p38, and JNK1 antibodies, respectively. Protein loading of the membrane was assessed by Western analysis using ␥-tubulin antibody (Sigma, T 6557).
Statistical analysis. Data are expressed as the means Ϯ SE. The StatView program was used to perform analysis of variance between different samples. Statistical significance was accepted at P Ͻ 0.05. All assay samples were performed in duplicate, and each experiment was repeated at least two times.
RESULTS
PMA upregulates SPRR expression in H441 cells.
Previous studies have demonstrated a close association between the expression of SPRR1 and induction of airway SCD (27) . To understand the molecular mechanisms of SCD in the distal bronchiolar region, we treated H441 cells with either DMSO (vehicle) or PMA (25 ng/ml) for different time periods as indicated. Total RNA was isolated, and Northern blot analysis was performed with comparable amount of RNA from each sample. As shown in Fig. 1A , SPRR1B mRNA levels are undetectable in the DMSO-treated control group (lane 1). However, by 3 h, PMA strongly enhanced the SPRR1B mRNA (lane 2), which reached a maximum by the 6-h time period and returned to lower levels by 14 h. All lanes had comparable amounts of 28S RNA, a housekeeping gene (Fig. 1A, bottom) . A similar pattern of SPRR1B protein expression was observed after PMA treatment. As shown in To distinguish SPRR1B expression from its ortholog SPRR1A, which shows significant sequence homology with the coding region of 1B, we analyzed the SPRR1B message levels employing a semiquantitative RT-PCR with gene-specific primers (see Table 1 ). A good corroboration was observed between the results of Northern blot and RT-PCR. PMA induced the expression of SPRR1B message levels in H441 (Fig. 1C ) similar to normal transformed bronchial epithelial cells HBE1 and S6 (1, 21) . We next analyzed the expression of other SPRR family members (SPRR1A, SPRR2A, and SPRR3) in H441 cells. PMA significantly induced SPRR1A and SPRR2A but not SPRR3 message levels in H441 cells. Together, these results indicate that PMA differentially induces the expression of SPRRs in Clara-like bronchiolar epithelial cells.
Induction of SPRR1B expression in H441 cells is regulated mainly at the transcription level.
Previous studies have shown that PMA downregulates the CCD marker expression, surfactant protein (SP)-A and SP-B, in H441 cells at the transcriptional and posttranscriptional levels, respectively (9, 13, 19, 20) . In the present study, we analyzed the regulation of SPRR1B in H441 cells to understand the molecular mechanisms (transcriptional and/or posttranscriptional) governing the induction of SCD in distal bronchiolar region. We mainly focused on SPRR1B regulation, as our previous studies and those of others have demonstrated a close association of SPRR1B expression with airway SCD both in vivo and in vitro (1, 21, 26) . H441 cells were pretreated with actinomycin D (10 g/ml) for 30 min before PMA exposure. RNA was isolated 6 h later, and SPRR1B message levels were analyzed by RT-PCR. As shown in Fig. 2A , PMA significantly induced the SPRR1B message levels (lane 2). However, pretreatment of cells with actinomycin D before PMA exposure significantly reduced inducible SPRR1B message levels (lane 4). To analyze whether PMA has any effect on SPRR1B mRNA stability, we For electrophoretic mobility shift assay (EMSA) analysis, both 5Ј and 3Ј wild-type 13-myristate 12-acetate (PMA)-responsive element (TRE) sequences of SPRR1B promoter are shown in bold, whereas mutated sites are underlined; only top strands are shown. AP-1, activator protein-1. treated cells with PMA for 6 h and then with actinomycin D. Cells were harvested at indicated time points thereafter. As shown in Fig. 2B , actinomycin D did not significantly affect the message levels stimulated by PMA. These results indicate that PMA-inducible expression of SPRR1B in H441 cells is regulated at the transcriptional level.
TREs located between the Ϫ150-and Ϫ84-bp promoter modulate PMA-inducible SPRR1B expression in H441 cells. To characterize the regulatory elements involved in PMA-inducible SPRR1B expression, several promoter mutants of SPRR1B linked to the Luc gene (Fig. 3A) were transiently transfected into H441 cells. We have mainly focused on the region from Ϫ150 to Ϫ84 bp, as it contains the motifs necessary for basal and PMA-inducible SPRR1B regulation in TBE cells (21) . Luc expression in the presence (dark bars) or absence of PMA (light bars) was analyzed. As shown in Fig. 3B , the 113-Luc construct, which bore the proximal TRE (Ϫ109), displayed basal level activity, whereas PMA significantly upregulated it. The 150-Luc construct, which contains both the proximal and distal TREs, exhibited both basal enhanced and a highlevel PMA-inducible activity. As shown in Fig. 3C , mutation of both TREs [double mutant (DM)] ablated both basal and PMA-inducible expression. Interestingly, mutation of either TRE alone did not have a significant effect on both basal and PMA-stimulated gene expression (data not shown). Interestingly, mutation of the promoter region between the two TREs (IN) also significantly reduced the basal level activity indicating the importance of these flanking sequences in gene regulation. These results are consistent with our previous studies that demonstrated a critical role for both these TREs in regulating PMA-inducible expression of SPRR1B (21) .
Analysis of AP-1 binding to the consensus AP-1 site and the SPRR1B promoter. The above data indicated that the TREs of SPRR1B promoter are necessary for PMA-stimulated expression in H441 cells. We therefore examined the patterns of AP-1 proteins binding to the consensus AP-1 site (Fig. 4) . Nuclear extracts were isolated from untreated and PMA-treated H441 cells incubated with a 32 P-labeled consensus AP-1 site (Fig.  4A) . A basal-level AP-1 protein binding was observed in the unstimulated cells (lane 1), which was significantly enhanced with PMA treatment (lane 2). We next examined the composition of AP-1 protein complex in untreated (Fig. 4B, lanes 2-7) and PMA-treated (Fig.  4B, lanes 9-14) H441 cells using antibodies specific for the individual Jun (c-Jun, JunB, and JunD) and Fos was separated, blotted, and hybridized with either 32 P-labeled SPRR1B cDNA probe. All lanes had comparable amount of 28S RNA, a housekeeping gene (bottom). B: an equal amount of cellular protein isolated from untreated and PMA-treated (25 ng/ml for 16 h) cells was separated on SDS-PAGE gel, and Western blot analysis was performed using SPRR1B antibodies. C: total RNA isolated as described above was subjected to RT-PCR using genespecific primers (see Table 1 ). Fig. 2 . PMA-stimulates SPRR1B expression in H441 cells mainly at the transcriptional level. A: cells were pretreated with either actinomycin D (Act D, 10 g/ml) or vehicle for 40 min and then exposed to PMA. After 6 h, cell cultures were harvested for RNA isolation, and RT-PCR was performed as in Fig. 1 . B: cells were first treated with PMA for 6 h and then exposed to Act D. Cell cultures were harvested at indicated time periods, and RT-PCR was performed using primers specific for SPRR1B or ␤-actin.
(c-Fos, Fra1, and Fra2) proteins. PMA significantly enhanced the binding of c-Jun, JunB, JunD, Fra1, and Fra2, but not c-Fos, as revealed by a supershift of their complexes with specific antibodies. Thus PMA enhanced the binding of Jun and Fos family members to a consensus AP-1 site similar to the patterns observed in HBE1, S6, and A549 cells (14) .
We next characterized the composition of the protein complex binding to the Ϫ150-to Ϫ84-bp region of the SPRR1B promoter, henceforth SPRR-TRE, that contains two critical TREs. As shown in Fig. 5A , vehicletreated H441 nuclear extracts (lanes 1 and 7) formed a DNA-protein complex that was enhanced significantly after PMA treatment (lane 8). The specificity of the DNA-protein complex was demonstrated by a competitive inhibition of complex formation by the unlabeled SPRR-TRE (self, lane 3) and consensus AP-1 site (AP-1, lane 4) . However, unlabeled DM did not block the complex formation (lanes 5 and 6) . Furthermore, mutation of TRE sites (for sequence, see Table 2 ) completely blocked AP-1 complex formation (data not shown). We next characterized the composition of the AP-1 protein complex binding to the SPRR1B promoter using specific antibodies as in Fig. 5B . Before the PMA treatment, cells displayed binding of JunD and Fra1  (lanes 4 and 5) . However, treatment of cells with PMA predominantly induced binding of JunB and Fra1  (lanes 8-14) . A slight enhancement of Fra2 binding was also noticed after PMA treatment (lane 13). Preincubation of nuclear extracts with normal rabbit serum showed no supershifting of the bands (data not shown). These results indicate that the AP-1 dimers, consisting of JunD and Fra1, bind to SPRR-TRE in the unstimulated state, whereas JunB and Fra1 bind to it upon PMA treatment.
AP-1 proteins differentially regulate SPRR1B promoter activity. Band shift profiles indicated a distinct pattern of AP-1 binding to SPRR-TRE compared with the consensus AP-1 site. Therefore, we used a panel of wt and/or dn mutants of the Jun (c-jun, junB, and Fig. 3 . PMA-responsive elements (TREs) located between Ϫ150 and Ϫ84 bp regulate SPRR1B promoter in H441 cells. A: the position of functional motifs of SPRR1B promoter. B: cells were grown to 70-80% confluence and then transfected with 100 ng of chimeric construct containing 150-SPRR1B promoter linked to a Luciferase (Luc) reporter gene along with 50 ng of ␤-galactosidase (␤-gal) vector, and transient transfections were carried out as described in MATE-RIALS AND METHODS. After 24-h incubation, medium was replaced with fresh culture medium containing either vehicle or PMA (25 ng/ml) for ϳ14 h, and Luc gene expression was analyzed. *P Ͻ 0.05 compared with vehicle-treated group (bar 3). C: transient transfection assays were performed as described in B, using either wild-type (WT) or mutated fragments (see Table 3 ) of SPRR1B promoter-reporter constructs. *P Ͻ 0.05 compared with vehicle-treated group (bar 1). **P Ͻ 0.05 compared with vehicletreated group (bar 5). DM, promoter with mutations in TRE sites; IN, promoter with mutations in between 2 TRE sites. junD) and Fos (fra1 and fra2) expression plasmids to determine the roles for these proteins in the regulation of SPRR1B. We did not study the role of c-Fos, because band shifts studies did not reveal any significant binding of c-Fos to either consensus AP-1 site or SPRR-TRE in both untreated and PMA-treated cells. Cells were transiently transfected with 150-Luc reporter plasmid along with the indicated expression vectors at comparable molar quantities, and Luc activity was analyzed. As shown in Table 3 , cotransfection of wt c-jun, junB, and junD expression vectors robustly enhanced the promoter activity to levels comparable with those observed with PMA treatment. Conversely, overexpression of c-Jun mutant with a defective in transactivation domain strongly inhibited both basal and PMAstimulated SPRR1B expression. As shown in Fig. 5B , Fra1 binds to the SPRR1B promoter predominantly, whereas a slight increase in Fra2 binding was noticed after PMA exposure. Therefore, we analyzed the role for Fra1 and Fra2 in SPRR1B promoter regulation. Overexpression of fra2 strongly suppressed PMA-stimulated Luc expression driven by SPRR1B promoter. Conversely, overexpression of fra1 upregulated the basal level activity, whereas it had no significant effect on PMA-stimulated promoter activity (Table 3) . Together, these results demonstrate that AP-1 dimers, with distinct composition, upregulate SCD in distal bronchiolar region. More recently, we showed that binding of Fra2 to the SPRR-TRE correlates with a loss of SPRR1B expression in A549 cells (14) . In contrast, overexpression of Fra1 strongly upregulates SPRR1B promoter-driven reporter gene expression in A549 cells (14) . These results indicate that Fra1 and Fra2 exert opposing effects on SPRR1B promoter in H441 cells. They also indicate that PMA-inducible expression of SPRR1B in distal bronchiolar cells is regulated by TRE sites and AP-1 proteins in a manner similar to that observed in proximal TBE cells, S6 and HBE1 (14) .
Ras regulates SPRR1B gene expression through Raf-1 and MAPKK kinase 1. To understand the signaling pathways that control PMA-inducible expression, we examined the role of Ras-Raf MAPK pathway. As said earlier, PMA activates PKC isoforms that in turn activate Ras, one of the downstream targets of PKC Fig. 5 . Analysis of H441 nuclear extracts binding to the SPRR1B promoter. EMSA was performed essentially as described in Fig. 4 except that a WT Ϫ150-to Ϫ84-bp SPRR1B promoter fragment ( Table 2 ) was used instead of the AP-1 probe. A:
32 P-end-labeled probe was incubated with 2 g of nuclear extracts isolated from vehicle (-) and PMA-treated (ϩ) H441 cells. For competition experiments, nuclear extracts were preincubated for 10 min with 25-or 100-fold molar excess of unlabeled probes before labeled probe was added. Values are means Ϯ SE. The effect of overexpression of wild-type (wt) and/or dominant negative (dn) mutants of Jun/Fos proteins on SPRR1B promoter activity. Upon reaching 70-80% confluence, cells were cotransfected with 150-SPRR1B-Luciferase (Luc) reporter (100 ng) and pCMV-␤-galactosidase (50 ng) in the presence of 50 ng of empty parental, wt, or dn expression vectors. The wt-c-jun and dn-c-jun (cloned in pCMV), wt-junB and wt-junD (cloned in SRalpha), pCMV-wt-fra1 and pCMV-wt-fra2 expression vectors were used. After 24-36 h transfection, cells were treated with either vehicle (untreated) or (PMA) (25 ng/ml). Reporter activity was analyzed as described in MATERIALS AND METHODS. Fold of promoter activation was calculated using the values of Luc activity of respective parental empty vector-transfected cells as one. ND, not determined. (30, 33) . To determine whether PMA upregulates SPRR1B expression through Ras, we cotransfected cells with ca-Ras or mutant dn-Ras expression vectors along with reporter construct. After 24 h, cells were treated with either PMA or vehicle, and the Luc expression was monitored. Expression of dn-Ras suppressed PMA-stimulated activity very significantly (Fig. 6A) , whereas it had no effect on basal expression. Conversely, overexpression of ca-Ras significantly stimulated promoter activity (ϳ2.5-fold) compared with vector-transfected controls (compare bar 1 with 5). We next investigated whether Raf-1, the downstream target of Ras (30), is required for gene induction (Fig. 6A) . Indeed, dn-c-Raf significantly suppressed PMA-stimulated, but not the basal-level, SPRR1B expression (compare bars 2 and 7). Together, these results indicate that PMA-activated Ras and Raf are critical for activating SPRR1B promoter. Ras also activates MAPKK kinase (MAPKKK) 1. Expression of dn-MAPKKK1 did not have any effect on basal gene expression, whereas it had a very significant effect (nearly 50% reduction) on PMA-stimulated promoter activity (Fig. 6B) . On the other hand, expression of ca-MAPKKK1 alone strongly augmented (ϳ4-fold) the Luc expression (Fig. 6B) .
MAPKK1, but not ERK1/2 MAPKs, regulates SPRR1B promoter in H441 cells. Recently, we showed that PMA-stimulated SPRR1B expression in BEAS-2B cells is mainly regulated by a MAPKK1/ERK-like MAPK pathway. However, ERK1/2, JNK, and p38 MAPKs did not appear to participate in this pathway (31) . We therefore focused our studies on the latter three (ERK, JNK, and p38) MAPKs and used both pharmacological and/or gene-specific dn mutants to evaluate whether PMA-inducible expression of SPRR1B in Clara-like H441 cells is mediated by the same signaling pathways as in proximal TBE cells. PD-98059, which prevents the activation of MAPKK1/2 (7), strongly suppressed both the basal (ϳ50%) and PMA-stimulated (ϳ100%) reporter gene expression (Fig. 7A) . These results have been further confirmed with UO-126 (data not shown), which specifically inhibits the function of activated MAPKK1 (7). Consistent with this, expression of a dn-MAPKK1 robustly suppressed PMA-stimulated reporter gene expression; conversely, ca-MAPKK1 significantly enhanced it (Fig. 7B) . Furthermore, PD-98059 slightly reduced basal and very significantly suppressed PMA-stimulated endogenous SPRR1B expression (data not shown). Thus MAPKK1 regulates both basal and PMA-stimulated expression of SPRR1B. We next examined the role of ERK1 and ERK2, the wellknown downstream targets of MAPKK1, in SPRR1B expression. As shown in Fig. 7C , overexpression of a dn-ERK1 or dn-ERK2 either alone or in combination (data not shown) did not suppress PMA-stimulated reporter gene expression. Intriguingly, treatment of H441 cells with PMA enhances the phosphorylation of ERK1/2 proteins (three-to fivefold). The ERK1/2 phosphorylation rapidly increased within 5 min and persisted at later periods (Fig. 7D) . Together, these results indicate that the MAPKK1 pathway regulates PMAstimulated SPRR1B expression. Paradoxically, ERK1 and/or ERK2 do not participate in it.
JNK1, but not p38 MAPK, regulates SPRR1B promoter in H441 cells. The JNK and p38 MAPK family members are activated in response to cellular injury, ultraviolet irradiation, inflammatory cytokines, and various environmental stresses (8) . Therefore, we next examined a role for p38 and JNK MAPKs in SPRR1B promoter regulation. To examine the role of p38 pathway, we used a chemical inhibitor, SB-202190 (SB). H441 cells were pretreated with SB (5-20 M), and endogenous SPRR1B mRNA levels were measured by RT-PCR analysis (Fig. 8A) . SB did not significantly suppress the PMA-stimulated mRNA expression of SPRR1B. Consistent with this, SB did not significantly inhibit either the basal or PMA-stimulated SPRR1B promoter-driven reporter gene expression (Fig. 8B) . Intriguingly, the kinase activity of p38, as measured by the phosphorylation of its substrate, activating transcription factor (ATF)-2, was significantly increased after PMA treatment (Fig. 6C) . Kinase activity increased onefold within 5 min of treatment and reached peak values (sixfold) after 15 min of treatment. The kinase activity remained elevated, below the peak level, even after 3 h. Together, these results indicate that the p38 MAPK pathway, though functionally active, does not appear to regulate PMA-stimulated SPRR1B expression in the Clara cell type.
We next examined the role of JNK1 in the regulation of SPRR1B promoter (Fig. 9) . Expression of dn-JNK1 mutant significantly diminished PMA-stimulated expression (Fig. 9A ). JNK1 and JNK2 activation was also confirmed by immunoprecipitation with isoform-specific antibodies followed by Western blot analysis with phospho-JNK-specific antibodies. As shown in Fig. 9B , PMA treatment significantly enhanced phosphorylation of JNK1 and JNK2 proteins in H441 cells. Consistent with this, enzyme activity of JNK1/2 was also enhanced after PMA treatment. PMA significantly increased JNK1 kinase activity (fourfold) that persisted over a longer time period (Fig. 9C) . Together, these results highlight the importance of JNK1 in regulation of PMA-stimulated SPRR1B expression in H441 cells (Fig. 10) .
DISCUSSION
In response to injury caused by various carcinogens, toxicants, and pollutants, airway epithelial cells (proximal and distal) lose their normal secretory functions and express squamous and keratinizing markers (16) . Induction of SCD in nonsquamous airway epithelium is initially thought to be a protective response, acting as a barrier against toxicants and pollutants; however, if not properly restored, this phenomenon might lead to airway epithelial cell transformation and bronchial carcinogenesis (11) . An understanding of the molecular with PMA (25 ng/ml) for indicated time periods, and cellular extracts were prepared. An equal amount of protein was separated on polyacrylamide gel, blotted, and analyzed using phospho-specific ERK1/2 antibody (top). Total ERK content of the samples was determined by immunoblot analysis using ERK2 antibodies (middle). Protein loading of the membrane was assessed by Western blot analysis using antibodies specific for ␥-tubulin (bottom).
events controlling the SCD process will help us in delineating the pathways involved in cellular injury and repair processes. It also provides an insight into the toxicant-induced airway disease and bronchial carcinogenesis. Clara cells are nonciliated epithelial cells that play an important role in respiratory function by expressing surfactants and a 10-kDa Clara cell protein, CC10 (16) . The present study demonstrates that PMA selectively induces the expression of SCD markers such as SPRRs (1A, 1B, and 2A, but not 3) in Clara-like bronchiolar epithelial cells. These results are in contrast with the previous studies that demonstrated the downregulation of CCD markers, such as CC10 and surfactant expression in H441 cells, upon exposure to PMA (9, 13, 19, 20) . Similarly, naphthalene and furan 4-ipomeanol induce cellular injury and suppress the expression of CCD markers, such as CC10 and cytochrome P-450, and also greatly enhance the expression of squamous cells (ϳ70-90%) in the distal bronchiolar region (23) . The exact role for SPRRs in the induction Fig. 8 . p38 MAPK pathway does not regulate PMA-stimulated SPRR1B promoter activation. A: the effect of p38 MAPK inhibitor SB-202190 (SB) on SPRR1B expression. Cells were grown to 80% confluence and then pretreated with SB for 30 min before PMA exposure. RNA was isolated and subjected to RT-PCR analysis as described in Fig. 1 . B: cells were transfected with 150-SPRR1B-Luc reporter and ␤-gal vectors. After transfection, cells were pretreated with either vehicle or SB for 30 min before PMA treatment. C: the effect of PMA on p38 activity. Cells were treated with PMA or DMSO, and cellular extracts were isolated as described in Fig. 7C and immunoprecipitated using p38 antibodies. The kinase activity of the immunoprecipitates was analyzed using activating transcription factor-2 as substrate. As a positive control for p38 activation, H441 cells were treated with puromycin (Pu, 2 g/ml for 30 min) or sorbitol (Sor, 10 mg/ml for 1 h). For ultraviolet (UV) treatment, cells were briefly exposed to UV (30 s) and incubated further for 1 h in the presence of culture medium. H441 cellular extracts were precipitated with JNK1 antibodies and Western blotted using phospho-specific JNK1/2 antibodies. C: the kinase activity of the immunoprecipitates (as in B) was analyzed using c-Jun as substrate. As a positive control, H441 cells were treated with anisomycin (Ani, 2 M) for 30 min, and JNK1 activity was analyzed as described above.
of SCD in Clara cells is unclear. However, it is well established that SPRRs act as cross-bridging proteins that participate in a cross-linking process of several CCE precursor proteins, such as loricrin (constituting 50-90% of CCE proteins) and involucrin (4, 24) . It is worth noting that a recent study demonstrated the actual participation of SPRR1B in the cornification of proximal TBE cells (5) . Therefore, we speculate that expression of SPRRs is an essential feature of SCD of distal bronchiolar cells and plays a very important role in providing a physical and chemical barrier against the environment. In support of this notion, a selective inducible expression of SPRRs, but not involucrin, was noticed in malignant keratinocytes that were induced to differentiate (32) , underscoring an important role for SPRRs in epithelial cell differentiation. Moreover, Chinese hamster ovary cells, a nondifferentiating cell type, express SPRR1 at specific stages of the cell cycle indicating that SPRRs may play a novel role in cell cycle progression and growth arrest (26) . Thus, transcriptional regulation of SPRR expression may provide an additional insight into molecular mechanisms governing the cellular differentiation of distal bronchiolar cells in response to toxic stimuli.
Abnormal expression and/or activation of AP-1 (Jun/ Fos) proteins in response to various growth factors and toxicants had been implicated in the development of various diseases and epithelial cell transformation (2) . The Jun family (c-Jun, JunB, and JunD) proteins can either homo-or heterodimerize with the Fos family (c-Fos, Fos-B, Fra1, and Fra2), bZIP transcription factors (e.g., ATF/cAMP response element binding protein, Maf/Nrf family members), as well as bHLH ZIP proteins (e.g., myoD and upstream stimulatory factor), resulting in differential DNA binding and transactivation (2). Subsequent AP-1 binding to the TREs regulates the transcription of a variety of genes that are involved in cell growth and differentiation and the injury-repair process, depending on cellular and promoter context (2) . Transcriptional analysis indicates that two functional TREs and AP-1 proteins mediate PMA-inducible SPRR1B expression in H441 cells. Moreover, the composition of AP-1 protein complex (Jun/Fra1 dimers) plays an important role in regulation of SPRR1B expression in H441 cells, in a manner similar to that observed in proximal S6 cells. PMA stimulates both Fra1 and Fra2 binding to the consensus AP-1 or TRE site (Fig. 4B) , whereas Fra1 more prominently binds to the SPRR1B promoter compared with Fra-2 (Fig. 5B) . These results emphasize the importance of cellular and promoter context, flanking residues such as GT/CAC and ETS-like motifs, on the regulation of AP-1-dependent gene expression. Indeed, mutation of these sites significantly reduced basallevel promoter activity (Fig. 3C) . Thus it is conceivable that both the activation and proximal availability of Fra1 and Fra2 with other proteins such as Jun members and/or cell type-specific factors might be involved in the regulation of SPRR1B expression in airway epithelial cells.
It is well established that PMA activates PKC isoenzymes, which in turn initiate a signaling cascade to stimulate expression of genes involved in cell growth and differentiation in different cell types. This is mediated by three well-studied distinct MAPKs, ERK, JNK, and p38 (6). ERK1 and ERK2 are mainly activated in response to growth stimuli, whereas JNK/ SAPK and p38 are activated by cellular stress and cytokine inflammation and can participate in differentiation and cell death (6) . In turn, these kinases activate transcription factors such as Elk-1, CCAAT/enhancer binding protein (C/EBP), C/EBP-homologous protein, c-Jun, and ATF-2 to modulate both cell typeand stimulus-specific target gene transcription (6) . Recently, we demonstrated that a MAPKK1-ERK-like kinase pathway regulates PMA-stimulated SPRR1B expression in TBE cells, whereas ERK1 and ERK2, JNK1/SAPK, and p38 had no effect (31) . Consistent with this, the present study demonstrates an involvement of MAPKK1 in PMA-stimulated SPRR1B transcription in H441 cells; however, ERK1/2 do not participate in such a process. Interestingly, dn-JNK1 mutant robustly suppressed PMA-inducible SPRR1B expression in H441 cells (Fig. 9) , indicating a regulatory role for JNK1 in the induction of SCD in distal bronchiolar cells. The fact that both MAPKK1 inhibitors and JNK1 mutant suppressed the PMA-stimulated SPRR1B promoter activation suggests the existence of either other ERK-related kinase(s) or crosstalk between MAPKK1 and JNK1 pathways that might regulate gene expression. Our data (Fig. 6) clearly support a role for Ras in SPRR1B regulation. Suppression of PMA-stimulated SPRR1B promoter activity by c-Raf and MAPKKK1 mutants indicates that Ras mediates its effects in part through the activation of c-Raf and MAPKKK1. However, in S6 cells, PMAstimulated SPRR1B promoter regulation by Ras does not require c-Raf but is mediated by MAPKKK1 (31) . Thus activation of SPRR1B expression, although regulated by a similar set of AP-1 proteins, may be differentially activated by a unique set(s) of MAPKs in proximal and distal airway epithelial cells.
